Abbasi, Fahim <br/><br/>
Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.  [electronic resource] 

 -  Metabolism: clinical and experimental  Mar 2009 
 - 373-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-8600 
<br/><br/><label>Standard No.: </label>10.1016/j.metabol.2008.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Body Mass Index<br/>Cardiovascular Diseases--epidemiology<br/>Cholesterol--blood<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--physiology<br/>Insulin Resistance<br/>Male<br/>Middle Aged<br/>Overweight--physiopathology<br/>Pioglitazone<br/>Risk Factors<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology